Access Purchased Content

General Psychiatry
General Psychiatry RSS Feed RSS

EXPERT Q&A

Mental Illness and Flourishing

March 4, 2022
Margaret Chisolm, MD

Margaret Chisolm, MDMargaret Chisolm, MD Vice Chair for Education in Psychiatry and Behavioral Sciences at Johns Hopkins University. Author of From Survive to Thrive: Living Your Best Life With Mental Illness (2021). Dr. Chisolm has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Photo credit: Greg Dohler

Dr. Margaret Chisolm shares how she and many of her colleagues at Johns Hopkins have found success in working with patients through a unique yet workable lens.
Read More

How to Prescribe Omega-3 Fatty Acids

March 4, 2022
Chris Aiken, MD.
Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Omega-3s are effective as augmentation of mood stabilizers in bipolar depression, and in some cases, they improve negative symptoms in early schizophrenia. The research is vast, but we narrow down when and how to use omega-3s in real-world practice.
Read More

A Prescription App for Insomnia

March 4, 2022
Jesse Koskey, MD.
Jesse Koskey, MD. Psychiatrist at Sensible Care, CA Dr. Koskey has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Psychiatrists can now prescribe a cognitive behavioral therapy app that takes basic therapy one step further with digital adaptions to improve insomnia, sleep apnea, and mood.
Read More
EXPERT Q&A

Raising the Bar in Schizophrenia Treatment

January 31, 2022
Brian Miller, MD, PhD, MPH
Brian Miller, MD, PhD, MPHBrian Miller, MD, PhD, MPH Professor of Psychiatry at the Medical College of Georgia, Augusta, and President of the Georgia Psychiatric Physicians Association. Dr. Miller receives research support from Augusta University, the National Institute of Mental Health, the Brain and Behavior Research Foundation, and the Stanley Medical Research Institute.
Dr. Miller discusses new options for negative symptoms, how to improve the therapeutic alliance, and what to do when clozapine doesn’t work in schizophrenia.
Read More

An Off-Label Guide to Gabapentin

January 31, 2022
Rajesh R. Tampi, MD, MS, DFAPA. and Chris Aiken, MD.
Rajesh R. Tampi, MD, MS, DFAPA. Professor of Medicine, Case Western Reserve University. Chairman, Department of Psychiatry & Behavioral Sciences, Cleveland Clinic Akron General, and Chief of Geriatric Psychiatry, Cleveland Clinic. Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. The authors have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Off-label gabapentin (Neurontin) got a bad rep when it missed the mark in bipolar disorder, but there may be something worth salvaging in this drug. Here, we weigh its pros and cons for anxiety, substance use disorders, sleep, pain, and hot flashes, and compare it to its underutilized cousin, pregabalin (Lyrica).
Read More
Try The New AskCarlat AI

Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

Available In The Carlat Toolkit
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
Featured Video
Featured Podcast
Recommended

About

Shop Online

Newsletters

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.